Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 6,149,377 | reported | 27 Mar 2017 | tx 1+1,190,476 |
| Whitehawk Therapeutics, Inc. | 4,416,446 | reported | 15 Mar 2017 | tx 1+762,995 |
| Audentes Therapeutics, Inc. | 4,129,638 | reported | 29 Sept 2017 | tx 1−672,000 |
| Relypsa Inc | 3,356,400 | reported | 25 Jul 2016 | tx 11+500,000−5,533,600 |
| Dimension Therapeutics, Inc. | 3,250,085 | reported | 27 Oct 2015 | tx 5+5,397,698−15,192,874 |
| BTHC VI Inc | 3,180,000 | reported | 21 May 2008 | tx 6+180,000−1,650,000 |
| RHYTHM PHARMACEUTICALS, INC. | 2,546,295 | reported | 10 Oct 2017 | tx 3+2,901,295−2,546,295 |
| Pacira BioSciences, Inc. | 2,446,000 | reported | 12 Mar 2012 | tx 12−340,841 |
| KALA BIO, Inc. | 2,375,279 | reported | 25 Jul 2017 | tx 3+2,375,279−10,707,985 |
| SUPERNUS PHARMACEUTICALS, INC. | 2,183,000 | reported | 13 Feb 2013 | tx 4−302,183 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jan 2018 | SALE | PALVELLA THERAPEUTICS, INC. | 16,128 | 7.35 USD | |
| 03 Jan 2018 | SALE | PALVELLA THERAPEUTICS, INC. | 1,693,492 | 7.35 USD | |
| 16 Nov 2017 | SALE | Loxo Oncology, Inc. | 46,680 | 72.46 USD | |
| 16 Nov 2017 | SALE | Loxo Oncology, Inc. | 43,300 | 73.48 USD | |
| 16 Nov 2017 | SALE | Loxo Oncology, Inc. | 8,377 | 76.23 USD | |
| 16 Nov 2017 | SALE | Loxo Oncology, Inc. | 71,598 | 75.37 USD | |
| 16 Nov 2017 | SALE | Loxo Oncology, Inc. | 100,045 | 74.49 USD | |
| 10 Oct 2017 | CONVERSION | RHYTHM PHARMACEUTICALS, INC. | 2,546,295 | — | |
| 10 Oct 2017 | PURCHASE | RHYTHM PHARMACEUTICALS, INC. | 355,000 | 17.00 USD | |
| 10 Oct 2017 | CONVERSION | RHYTHM PHARMACEUTICALS, INC. | 2,546,295 | 0.00 USD | deriv |
| 29 Sept 2017 | SALE | Audentes Therapeutics, Inc. | 672,000 | 28.25 USD | |
| 27 Sept 2017 | SALE | Roka BioScience, Inc. | 52,301 | 0.92 USD | |
| 26 Sept 2017 | SALE | Roka BioScience, Inc. | 706 | 1.03 USD | |
| 26 Sept 2017 | SALE | Roka BioScience, Inc. | 74,096 | 1.03 USD | |
| 27 Sept 2017 | SALE | Roka BioScience, Inc. | 498 | 0.92 USD | |
| 05 Sept 2017 | SALE | GLAUKOS Corp | 189,792 | 39.63 USD | |
| 01 Sept 2017 | SALE | GLAUKOS Corp | 1,038 | 37.72 USD | |
| 01 Sept 2017 | SALE | GLAUKOS Corp | 109,040 | 37.72 USD | |
| 31 Aug 2017 | SALE | GLAUKOS Corp | 424 | 37.82 USD | |
| 31 Aug 2017 | SALE | GLAUKOS Corp | 44,498 | 37.82 USD | |
| 05 Sept 2017 | SALE | GLAUKOS Corp | 553 | 40.77 USD | |
| 05 Sept 2017 | SALE | GLAUKOS Corp | 58,047 | 40.77 USD | |
| 05 Sept 2017 | SALE | GLAUKOS Corp | 1,808 | 39.63 USD | |
| 05 Sept 2017 | SALE | GLAUKOS Corp | 1,651 | 37.94 USD | |
| 05 Sept 2017 | SALE | GLAUKOS Corp | 173,349 | 37.94 USD |
3 purchases reported after at least 12 months of silence — most recent on 06 Jul 2015.